A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease Strategies to bring clinical trials closer to patients gained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback